Effectiveness [qlco]
telmisartan [orch, phsu]
Alone [qnco]
Combination Therapy [topp]
controlling [ftcn]
Blood Pressure [orgf]
vascular [bpoc]
Elderly [popg]
Elderly [popg]
Patients [podg]
Age [orga]
Hypertension [dsyn]
High Risk [qlco]
vascular [bpoc]
Complications [patf]
Diabetes [dsyn]
Present [qnco]
Anti-Hypertensive Drugs [phsu]
arrested [dsyn]
Renin-angiotensin system [bdsy]
effective [qlco]
controlling [ftcn]
Blood Pressure [orgf]
Adult [aggp]
Elderly [popg]
Patients [podg]
Renin-angiotensin system [bdsy]
inhibitors [chvf]
Benefits [qnco]
Classic [qlco]
effects [qlco]
Including [ftcn]
Reducing [qlco]
new onset [fndg]
Diabetes [dsyn]
CARDIOVASCULAR [bdsy]
Discovery [acty]
Renin-angiotensin system [bdsy]
Inhibitor [qlco]
Angiotensin II Type 1 Receptor [aapp, rcpt]
telmisartan [orch, phsu]
Activate [ftcn]
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]
PPAR gamma [aapp, rcpt]
Established [qlco]
antidiabetic drug [phsu]
Target [ftcn]
Unique [qlco]
PREVENT [phsu]
cardiovascular complications [patf]
High Risk [qlco]
Elderly [popg]
Patients [podg]
Hypertension [dsyn]
new onset [fndg]
Diabetes [dsyn]
Large [qnco]
Clinical Trials [resa]
ONGOING [idcn]
telmisartan [orch, phsu]
Alone [qnco]
Combination [qlco]
Ramipril [orch, phsu]
Global [spco]
End Point [qlco]
Trial [resa]
Transcend [bodm]
telmisartan [orch, phsu]
randomized [resa]
Assessment [hlca]
Study [mnob]
intolerant [ftcn]
Subject [grup]
Cardiovascular disease [dsyn]
Assessed [acty]
antidiabetic [phsu]
effects [qlco]
telmisartan [orch, phsu]
collective [orgt]
Suggest [idcn]
telmisartan [orch, phsu]
promise [idcn]
Drug [phsu]
controlling hypertension [fndg]
Reducing [qlco]
vascular [bpoc]
High Risk [qlco]
Elderly [popg]
Patients [podg]
new onset [fndg]
Diabetes [dsyn]
